loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X

Approved Drug Products containing 20839 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 SANOFI AVENTIS US (2)

filter

01 TABLET;ORAL (2)

filter

01 RX (2)

filter

01 PLAVIX (2)

filter

01 Yes (2)

URL Supplier Web Content
TABLET; ORAL
EQ 75MG BASE
1997-11-17
20839
PLAVIX
RX
Yes
AB
Sanofi Company Banner

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
TABLET; ORAL
EQ 300MG BASE
2007-09-20
20839
PLAVIX
RX
Yes
AB
Sanofi Company Banner

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier

Looking for FDA Orange Book APPLICATION 20839

Looking for FDA Orange Book APPLICATION 20839 2

19

Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their notable products is CLOPIDOGREL BISULFATE, with a corresponding application number 20839.

Regulatory Information RX

With a dosage strength EQ 75MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 1997-11-17

Therapeutic Equivalence (TE) Code AB

18

Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their notable products is CLOPIDOGREL BISULFATE, with a corresponding application number 20839.

Regulatory Information RX

With a dosage strength EQ 300MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2007-09-20

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY